Tandem Diabetes Care is a medical devices business based in the US. Tandem Diabetes Care shares (TNDM) are listed on the NASDAQ and all prices are listed in US Dollars. Tandem Diabetes Care employs 2,600 staff and has a trailing 12-month revenue of around $790.3 million.
Finder Award
SoFi Invest
Finder Award
eToro
tastytrade
| Latest market close | $19.33 |
|---|---|
| 52-week range | $21.01 - $58.82 |
| 50-day moving average | $28.81 |
| 200-day moving average | $35.06 |
| Wall St. target price | $42.43 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-3.32 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $19.33 from 2023-09-25
| 1 week (2023-09-20) | -15.11% |
|---|---|
| 1 month (2023-08-25) | -28.57% |
| 3 months (2023-06-27) | -26.33% |
| 6 months (2023-03-27) | -52.18% |
| 1 year (2022-09-27) | -58.46% |
|---|---|
| 2 years (2021-09-27) | -84.04% |
| 3 years (2020-09-25) | 108.4 |
| 5 years (2018-09-27) | 42.79 |
| Revenue TTM | $790.3 million |
|---|---|
| Gross profit TTM | $413 million |
| Return on assets TTM | -6.69% |
| Return on equity TTM | -57.64% |
| Profit margin | -28.4% |
| Book value | $5.06 |
| Market Capitalization | $1.4 billion |
TTM: trailing 12 months
We're not expecting Tandem Diabetes Care to pay a dividend over the next 12 months.
Tandem Diabetes Care's shares were split on a 1:10 basis on 9 October 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tandem Diabetes Care shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Tandem Diabetes Care shares which in turn could have impacted Tandem Diabetes Care's share price.
Over the last 12 months, Tandem Diabetes Care's shares have ranged in value from as little as $21.01 up to $58.8189. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tandem Diabetes Care's is 0.8724. This would suggest that Tandem Diabetes Care's shares are less volatile than average (for this exchange).
Tandem Diabetes Care, Inc. , a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories.
Everything we know about the Discord IPO, plus information on how to buy in.
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.